type sequence filename description text html head title title head body bgcolor white style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size font family time roman align right exhibit style margin margin bottom font size font family time roman align center amended restated license agreement style margin margin bottom text indent font size font family time roman this amended restated license agreement agreement entered into december restatement date miragen therapeutic corporation organized existing under state delaware miragen santaris pharma corporation organized existing under denmark santaris miragen santaris each referred individually party collectively party style margin margin bottom font size font family time roman whereas miragen engaged research development commercialization pharmaceutical product directed target style margin margin bottom font size font family time roman whereas santaris developed owns proprietary right certain technology relating discovery novel oligonucleotides active against selected molecular target style margin margin bottom font size font family time roman whereas miragen santaris desire santaris grant license miragen certain such technology allow miragen discover novel oligonucleotides active against certain target further research develop commercialize product containing such oligonucleotides style margin margin bottom font size font family time roman whereas party entered into license agreement original agreement june nbsp effective date amended such license agreement october nbsp first amendment party desire further amend restate such agreement entirety style margin margin bottom font size font family time roman therefore party agree follows style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign definition table style margin margin bottom margin left font size font family time roman when used this agreement following capitalized term whether used singular plural shall have meaning forth this article style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign active ingredient mean clinically active material pharmaceutical product which provides pharmacological activity excluding formulation component such coating stabilizer excipients solvent controlled release technology table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign align left style margin margin bottom font family time roman font size affiliate mean with respect person entity other person entity that control controlled under common control with such person entity purpose this agreement person entity shall deemed control entity owns control directly indirectly least table style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign equity security subject entity entitled vote election director case entity that corporation election corresponding managing authority otherwise power direct management policy such other entity table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign combination product mean following nbsp pharmaceutical product that contains product least other active ingredient that product nbsp product that contains product medical device nbsp combination product another pharmaceutical product that contains least other active ingredient that product where such product formulated together sold together single product each case invoiced product except with respect section nbsp this section nbsp reference product this agreement shall deemed include combination product table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign commercialization commercialize mean activity directed marketing promoting distributing importing exporting using commercial purpose selling product table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign confidential information party mean know other information including information material whether patentable regarding such party technology product business that communicated form other party pursuant confidentiality agreement between party dated august nbsp pursuant mutual disclosure agreement between party dated september nbsp pursuant this agreement provided that each case such know other information material identified confidential time disclosure term condition this agreement shall considered confidential information each party table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign control controlled mean ability party grant other party license sublicense access know patent provided herein without violating term agreement other arrangement with third party table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign cost good sold mean with respect certain quantity actual cost paid santaris third party manufacture supply such component thereof third party manufacturing cost extent such procured from third party such cost otherwise included third party manufacturing cost santaris fasc manufacture supply such each case plus nbsp nbsp nbsp nbsp calculation will based upon accepted contract manufacturing industry standard including allocation overhead excluding allocation idle capacity generally accepted accounting principle applied consistently across santaris product table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign development develop mean conduct clinical clinical clinical development activity including toxicology pharmacology other similar study test method development stability testing process development formulation development delivery system development quality assurance quality control development statistical analysis clinical study including post approval study regulatory affair pharmacovigilance other activity directed obtaining regulatory approval development shall include activity relating discovery miragen compound table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign diligent effort mean with respect product application reasonable level resource effort consistent with exercise prudent scientific business judgment that company comparable size resource within biotechnology industry applicable party affiliate extent applicable case miragen sublicensees would reasonably devote product similar stage research development commercialization with similar market potential resulting from research effort based condition then prevailing least those effort resource normally used applicable party affiliate extent applicable case miragen sublicensees with respect product similar stage research development commercialization with similar market potential resulting from such party affiliate extent applicable case miragen sublicensees research effort based condition then prevailing diligent effort shall determined taking into account diligent effort requires that applicable party nbsp promptly assign responsibility research development commercialization activity with respect product specific employee contractor held accountable progress monitoring such progress going basis nbsp consistently seek achieve specific meaningful objective timeline carrying such research development commercialization activity nbsp consistently make implement decision allocate resource designed advance progress with respect such objective timeline table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign discovery discover mean activity relating compound prior such compound development table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign european medicine agency mean european medicine agency successor entity thereto table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign equity agreement mean series preferred stock issuance agreement dated effective date between miragen santaris amended restated investor right agreement amended restated sale agreement amended restated voting agreement each amended restatement date table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign exclusive research license shall have meaning forth section nbsp table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign existing target mean nbsp each target that were subject this agreement prior restatement date which described schedule nbsp target comprising existing target pursuant section nbsp nbsp target replacing such target pursuant section table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign fasc mean with respect particular quantity fully allocated cost manufacturing such which shall comprise direct cost including labor material energy utility quality control other cost incurred directly allocated specifically manufacturing such component thereof indirect cost including specifically allocable production delivery such calculation fasc will based upon accepted contract manufacturing industry standard including allocation overhead excluding allocation idle capacity generally accepted accounting principle applied consistently across santaris product prior commencement manufacturing party shall agree more detailed provision concerning determination fasc manner consistent with provision this definition table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign mean united state food drug administration successor entity thereto table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign field mean treatment prevention mitigation disease disorder medical condition human table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign first commercial sale mean with respect product country territory first sale such product behalf miragen affiliate sublicensees third party such country after such product been granted marketing approval such country table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign mean table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign improvement platform technology mean table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign mean nbsp investigational drug application defined nbsp part filed with nbsp application clinical trial authorisation pursuant directive regulation promulgated thereunder initiating clinical trial european union nbsp with respect argentina australia brazil canada israel japan mexico zealand norway russia singapore switzerland turkey other country regulatory jurisdiction which time question common site clinical trial cardiovascular indication intended submission european medicine agency nbsp equivalent application described subsection nbsp nbsp such country regulatory jurisdiction nbsp there equivalent application described subsection nbsp nbsp such country regulatory jurisdiction enrollment first subject human clinical trial table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign acceptance mean nbsp with respect defined section nbsp nbsp first date following submission such which clinical testing product human subject lawfully commence country such submission nbsp with respect defined section nbsp enrollment first subject human clinical trial product table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign enabling study mean pharmacokinetic toxicology study required meet requirement filing including toxicology study that conducted compliance with table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign meaning forth section nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign know mean invention discovery development data information process method practice technique material result other know tangible intangible form whether patentable including specification formulation formula software algorithm technology test data including pharmacological biological chemical biochemical toxicological clinical test data analytical quality control data stability data study procedure table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign compound mean single stranded oligonucleotide that comprised contains least monomer provided that such oligonucleotide table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign monomer mean ribonucleoside that claimed patent controlled santaris effective date time during term such ribonucleoside shall remain monomer after expiration such patent table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign platform technology mean table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign specification mean specification forth schedule amended santaris from time time upon prior written notice miragen provided that such amendment applies table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign marketing approval mean nbsp approval drug application biologics license application filed with that necessary commercialization product united state nbsp approval marketing authorization application filed with european medicine agency product under centralized european procedure that necessary commercialization product country european union nbsp equivalent marketing approval other applicable jurisdiction territory table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign miragen change control mean nbsp merger reorganization consolidation miragen with entity that affiliate miragen restatement date that result voting security miragen outstanding immediately prior thereto ceasing represent least combined voting power surviving entity immediately after such merger reorganization consolidation nbsp entity that affiliate miragen restatement date becoming beneficial owner more combined voting power outstanding security miragen nbsp sale other transfer entity that affiliate miragen restatement date substantially miragen business asset which this agreement relates provided that miragen change control shall include nbsp transaction series transaction principally bona fide equity financing purpose which cash received miragen successor indebtedness miragen cancelled converted combination thereof nbsp reincorporation merger consolidation effected exclusively purpose changing domicile miragen another jurisdiction table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign miragen compound mean compound targeting miragen target table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign miragen compound patent mean patent that nbsp cover composition matter dose formulation import sale miragen compound product nbsp contain claim that clarity patent will considered patent notwithstanding anything otherwise contrary foregoing miragen compound patent shall include miragen target technology table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign miragen patent meaning forth section table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign miragen product technology mean nbsp know controlled miragen affiliate sublicensees time during term prior termination this agreement with respect terminated miragen target nbsp patent controlled miragen affiliate sublicensees time during term each case that nbsp necessary develop commercialize reversion product actually used practiced miragen affiliate sublicensees with respect development commercialization such reversion product prior applicable effective date termination such terminated miragen target santaris affiliate sublicensees with respect development commercialization such reversion product prior first dosing first patient first phase clinical trial such reversion product nbsp applicable effective date termination such terminated miragen target time first dosing first patient first phase clinical table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign trial such reversion product expected used further development commercialization such reversion product avoidance doubt miragen product technology shall nbsp include know created miragen affiliate sublicensees course practicing research license product license with respect terminated miragen target prior such termination patent claiming invention conceived reduced practice miragen affiliate sublicensees course practicing research license product license with respect terminated miragen target prior such termination provided each case that such know patent satisfies criterion forth subsection nbsp nbsp this section nbsp nbsp exclude with respect reversion product that combination product know patent controlled miragen affiliate sublicensees that necessary develop commercialize active ingredient medical device other than device delivery administration product other pharmaceutical product described subsection nbsp section nbsp such reversion product that product notwithstanding anything otherwise contrary foregoing miragen product technology shall include miragen compound patent miragen target technology table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign miragen target mean each existing target target table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign miragen target technology mean table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign know controlled miragen affiliate sublicensees during term prior termination this agreement with respect terminated miragen target that relates subject matter described clause nbsp nbsp subsection nbsp below table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign patent controlled miragen affiliate sublicensees during term prior termination this agreement with respect terminated miragen target that claim cover nbsp miragen target such terminated miragen target including sequence expression method producing purifying such miragen target nbsp research tool relating such miragen target including material process preparing such miragen target assay reagent prepared from such miragen target process preparation method using such miragen target material assay reagent screen assay select otherwise identify composition matter that bind such miragen target alters activity such miragen target nbsp compound containing monomer therapeutic purpose wherein therapeutic mechanism action mediated binding such compound such miragen target resulting regulation modulation such miragen target table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign miragen technology mean miragen product technology miragen target technology table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign patent mean patent listed schedule table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign sale mean gross amount invoiced sale product miragen affiliate sublicensees selling person person entity other than selling person affiliate sublicensees following deduction each case extent specifically related product taken selling person otherwise paid accrued selling person table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign table style margin margin bottom margin left font size font family time roman sale product between miragen affiliate sublicensees resale shall included within sale disposition product clinical trial sample shall included calculation sale style margin margin bottom margin left font size font family time roman sale combination product purpose calculating miragen payment obligation hereunder shall determined follows style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign event more product sold part combination product particular country product contained combination product sold separately such country sale such product purpose determining payment based sale shall determined multiplying sale combination product such country during applicable sale reporting period fraction where each case during applicable sale reporting period table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign event more product sold part combination product sold separately finished form such country other product included combination product sold separately finished form such country sale such product purpose determining payment based sale shall determined multiplying sale combination product such country fraction where each case during applicable sale reporting period under circumstance exceed hundred percent table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign event that more product sold part combination product sold separately finished form country other product included combination product such country sold separately sale such product purpose determining payment based sale shall determined multiplying sale combination product such country fraction where each case during applicable sale reporting period table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign event that that more product sold part combination product sale such product determined using method above sale such product purpose determining payment based such sale shall agreed upon good faith party basis respective fair market value such product other product included such combination product table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign target mean target comprising target each target target which miragen exercise product license option target replacing such target pursuant section nbsp clarity target excludes existing target table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign target mean target that includes target table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign exclusive research license shall have meaning forth section nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign patent mean nbsp patent nbsp patent application including provisional provisional application substitution continuation continuation part division renewal patent granted thereon nbsp patent addition reissue reexamination extension restoration existing future extension restoration mechanism including supplementary protection certificate equivalent thereof nbsp inventor certificate nbsp other form government issued right substantially similar foregoing table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign phase clinical trial mean human clinical trial product human subject according amended equivalent appropriate foreign jurisdiction table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign phase clinical trial mean clinical trial product patient principal purpose which establish clinical proof principle obtain sufficient information about such product safety efficacy permit design further clinical trial that would satisfy requirement part similar clinical study prescribed regulatory authority country other than united state table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign phase clinical trial mean pivotal clinical study product which study designed nbsp establish that such product safe efficacious intended nbsp define warning precaution adverse reaction that associated with such product dosage range prescribed nbsp support regulatory approval such product nbsp generally consistent with amended successor regulation other comparable regulation imposed regulatory authority country other than united state table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign product mean pharmaceutical product containing consisting more miragen compound table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign product license meaning forth section table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign product license option meaning forth section nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign regulatory approval mean technical medical scientific other license registration authorization approval regulatory authority necessary development commercialization product regulatory jurisdiction including marketing approval table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign regulatory authority mean agency department bureau commission council other governmental entity involved granting regulatory approval jurisdiction table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign regulatory documentation mean nbsp regulatory file relating development commercialization product including license extent transferable minute meeting telephone conference with regulatory authority validation data preclinical clinical study test related product including original data case report form study file relating aforementioned study test audit report clinical study plus application amendment thereto regulatory approval annual report safety report associated therewith drug master file which miragen affiliate possession control correspondence with regulatory authority regarding marketing status product nbsp record maintained under cgmps other record keeping reporting requirement regulatory authority including correspondence communication with regulatory authority connection with product including advertising promotion document adverse event file complaint file manufacturing record table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign research license meaning forth section nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign retained compound mean nbsp compound that designed being developed exert biological effect through binding miragen target that miragen target terminated miragen target nbsp other compound with potential therapeutic activity that compound table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign reversion product mean with respect particular terminated miragen target nbsp miragen compound that target particular miragen target such terminated miragen target identified miragen prior termination this agreement such terminated miragen target nbsp product that contains consists miragen compound described clause nbsp above wherein such product form existence contemplated prior such termination avoidance doubt such product described clause nbsp above such existing contemplated form contain miragen compound described clause nbsp above table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign royalty period mean product product country country basis period time beginning date first commercial sale such product such country extending until later nbsp year after such first commercial sale such product such country nbsp first date which there valid claim patent such country table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign santaris change control mean nbsp merger reorganization consolidation santaris with entity that affiliate santaris restatement date which result voting security santaris outstanding immediately prior thereto ceasing represent least combined voting power surviving entity immediately after such merger reorganization consolidation nbsp entity that affiliate santaris restatement date becoming beneficial owner more combined voting power outstanding security santaris nbsp sale other transfer entity that affiliate santaris restatement date substantially santaris business asset which this agreement relates provided that santaris change control shall include nbsp transaction series transaction principally bona fide equity financing purpose which cash received santaris successor indebtedness santaris cancelled converted combination thereof nbsp reincorporation merger consolidation effected exclusively purpose changing domicile santaris another jurisdiction table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign santaris technology mean nbsp know controlled santaris that disclosed miragen under this agreement nbsp patent controlled santaris effective date during term that nbsp necessary development commercialization miragen compound product nbsp nbsp actually used practiced miragen affiliate sublicensees with respect such miragen compound product prior first dosing first patient first phase clinical trial such miragen compound product nbsp time first dosing first patient first phase clinical trial such miragen compound product expected used further development commercialization such miragen compound product notwithstanding anything otherwise contrary foregoing santaris technology shall include miragen compound patent platform technology except provided section nbsp shall include table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign sublicense mean nbsp sublicense granted miragen affiliate sublicensee under exclusive research license product license accordance with section nbsp applicable nbsp license granted miragen affiliate under miragen compound patent research develop make sell offer sell import product table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign sublicense revenue mean consideration form received miragen affiliate exchange grant miragen affiliate sublicense excluding nbsp nbsp consideration reimbursement cost expense such research cost development cost manufacturing cost promotional expense patent cost like nbsp consideration loan other than extent loan forgiven credited toward other payment obligation exchange equity miragen affiliate nbsp royalty paid sublicensee other than affiliate miragen miragen affiliate with respect sale product such sublicensee sublicense royalty each case except extent specifically included below sublicense revenue shall include following amount paid sublicensee other than affiliate miragen miragen affiliate exchange grant such sublicense table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign license maintenance table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign milestone payment including development regulatory sale based milestone payment other than payment paid sublicensee solely account provided that respect respect table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign portion minimum royalty payment received miragen affiliate excess sublicense royalty received table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign profit sharing revenue product table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign promotion distribution joint marketing excess payment reimbursement cost expense incurred miragen affiliate connection with such promotion distribution marketing activity table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign payment supply product excess such product component thereof calculated using definition forth section fasc applied mutatis mutandis miragen affiliate with respect product component thereof instead component thereof table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign payment miragen affiliate performance research development activity extent that such payment exceed both nbsp miragen affiliate actual cost performing such research development activity amount paid miragen affiliate third party similar research development activity performed miragen affiliate nbsp miragen affiliate have been paid third party similar research development activity amount paid biotechnology company length transaction with third party similar research development activity relating product technology identified created developed such biotechnology company table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign sublicensee other than affiliate miragen issue publicly traded equity debt security miragen affiliate connection with sublicense grant fair market value such security issued miragen affiliate such fair market value determined method used determine amount paid miragen affiliate such method specified average closing price such security twenty nbsp business preceding date issuance miragen affiliate cash consideration paid miragen affiliate such security table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign miragen affiliate issue equity debt security sublicensee other than affiliate miragen connection with sublicense grant consideration received miragen affiliate such security extent such consideration exceeds fair market value such security such fair market value determined nbsp such security then publicly traded nbsp such security then publicly traded method used determine amount paid such sublicensee such method specified average closing price such security twenty nbsp business preceding date issuance such sublicensee table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign sublicensee mean with respect particular product either nbsp affiliate miragen third party whom miragen granted sublicense right including option obtain sublicense nbsp third party whom miragen granted right promote distribute product such third party principally responsible marketing promotion booking sale such product within particular country territory excluding wholesaler physical distributor subcontractor contract sale force other third party promoting distributing product booking sale behalf miragen table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign target mean sequence through which proposed drug therapeutic mediates intended mediate therapeutic activity table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign target mean miragen target that restatement date target consist three miragen target described schedule existing target sequence that comprise other target shall designated party after each miragen target proposed miragen included target clear gate keeping procedure forth section nbsp shall comparable size nature scope miragen target included existing target table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign target patent mean patent claiming nbsp target including sequence expression method producing purifying such target nbsp research tool relating such target including material process preparing such target assay reagent prepared from such target process preparation method using such target material assay reagent screen assay select otherwise identify composition matter that bind such target alters activity such target nbsp compound therapeutic purpose wherein therapeutic mechanism action mediated binding such compound such target resulting regulation modulation such target notwithstanding anything otherwise contrary foregoing target patent shall include platform technology santaris technology table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign targeting mean when used describe relationship between compound target that such compound nbsp such target nbsp designed being developed exert biological effect through binding such target purpose this section nbsp mean that clarity compound that target table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign term meaning forth section table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign terminated miragen target meaning forth schedule table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign territory mean entire world table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign third party mean person other than miragen santaris their respective affiliate table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign upfront payment mean nbsp consideration form received miragen affiliate from sublicensee other than affiliate miragen upon execution agreement granting sublicense with respect target exchange grant such sublicense miragen affiliate such sublicensee nbsp miragen affiliate grant third party right including option obtain sublicense with respect target including target that subsequently becomes target then upon earlier nbsp nbsp date such earlier event referred trigger date nbsp consideration form received miragen affiliate from such third party pursuant agreement granting such right option agreement prior trigger date nbsp table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign consideration form received miragen affiliate from such third party under option agreement upon exercise such right obtain such sublicense such target exchange grant such sublicense such target each case nbsp nbsp excluding nbsp consideration reimbursement cost expense such research cost development cost manufacturing cost promotional expense patent cost like nbsp consideration loan other than extent loan forgiven credited toward other payment obligation exchange equity miragen affiliate nbsp consideration that reasonably allocable sublicense grant other right existing target target that never becomes target license sublicense option receive license sublicense intellectual property other than platform technology santaris technology case nbsp except extent such exclusion would included sublicense revenue pursuant section nbsp nbsp nbsp paid after execution such agreement after exercise such right applicable event that option agreement miragen affiliate also grant third party option other right that pertains other therapeutic target addition target which such third party exercise option obtains sublicense then consideration received under option agreement that pertains both such target other therapeutic target shall addition described above applicable allocated among such therapeutic target purpose determining amount upfront payment follows such therapeutic target similar stage development when such consideration received then consideration received shall allocated equally among such therapeutic target least such therapeutic target different stage development from another such therapeutic target such time then party shall negotiate good faith reasonable allocation consideration received among such therapeutic target based development stage each such therapeutic target such time example miragen receives from third party under such option agreement which payment pertains therapeutic target which include target which such third party exercise option obtains sublicense such therapeutic target same stage development when payment received then upon such third party exercise such option with respect target included such three therapeutic target such payment shall included upfront payment provided that such payment exchange such option none exclusion forth nbsp apply table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign valid claim mean claim unexpired issued patent that shall have been dedicated public disclaimed held invalid unenforceable court government agency competent jurisdiction unappealed unappealable decision table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign research activity table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign exclusive research license table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign effective date miragen granted exclusive research license miragen target included existing target prior anniversary restatement date subject clearance gate keeping procedure forth section nbsp miragen shall have right nominate include exclusive research license product license additional target existing target existing target such proposed target fails such gate keeping procedure miragen shall have right propose alternative target submission such gate keeping procedure until proposed target pass gate keeping procedure thereby becomes existing target provided however that with respect alternative submission that submitted after anniversary restatement date each such alternative submission shall made within after miragen receives notice that immediately prior submission failed gate keeping procedure table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign respect each existing target santaris hereby grant miragen exclusive license with right grant sublicenses provided below under platform technology santaris technology solely discover identify clinical research development otherwise conduct clinical research miragen compound targeting such existing target conduct clinical development product containing such miragen compound field exclusive research license subject section nbsp following term condition table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign miragen grant sublicenses under exclusive research license only sublicensees granted product license under section nbsp such sublicenses shall subject mutatis mutandis term condition forth section nbsp with respect sublicenses under product license provided that miragen shall grant sublicenses under exclusive research license with respect existing target unless until nbsp nbsp such sublicenses granted connection with grant right such sublicensees under certain know patent controlled miragen affiliate that pertains more miragen compound targeting such existing target purpose this section nbsp mean that nbsp nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign sublicenses under exclusive research license discover miragen compound shall granted solely purpose applicable existing target purpose this section nbsp mean with respect miragen compound existing target which such miragen compound bind compound that thereby table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign except connection with sublicenses granted accordance with section nbsp this section nbsp option such sublicense third party evaluation interest obtaining such sublicense option miragen shall perform service other activity under research license benefit third party table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign notwithstanding anything otherwise contrary this agreement know within platform technology that pertains table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign exclusive research license table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign respect santaris hereby grant miragen affiliate exclusive license without right sublicense under platform technology santaris technology exclusive research license together with exclusive research license research license miragen shall have right grant sublicenses under exclusive research license such time miragen longer right select target under section nbsp replace target under section nbsp exclusive research license shall become limited target comprising target including those target that replacement prior target excluding prior target that have been replaced table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign replacement target table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign subject procedure limitation forth this section nbsp miragen replace each miragen target target time prior nbsp case existing target anniversary restatement date nbsp case existing target family each target anniversary date such target designated existing target pursuant section nbsp target pursuant section nbsp applicable table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign miragen desire replace miragen target shall notify santaris identify such miragen target target provide information described section nbsp proposed replacement target proposed replacement target target such proposed target each member target pass such gate keeping procedure then subject compliance with subsection nbsp below shall designated existing target target shall designated existing target case this agreement shall terminate with respect target target table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign that been replaced term section nbsp shall apply such proposed target fails such gate keeping procedure then shall designated existing target case miragen propose alternative target replace such miragen target subject same gate keeping procedure until proposed target pass gate keeping procedure designated existing target provided that each alternative proposal that submitted after applicable time period forth section nbsp shall submitted within after immediately prior proposal fails gate keeping procedure table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign miragen replace each miragen target only except that replace target table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign within after proposed replacement target pass gate keeping procedure miragen shall santaris amount required under section nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign target gate keeping procedure table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign respect each target that subject gate keeping procedure including provided section miragen shall provide notice proposed target target notice target notice miragen will identify proposed target comprising target provision full length sequence number table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign within after receipt target notice santaris shall either table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign notify miragen writing that none target proposed target excluded target defined below which case proposed target shall deemed have passed gate keeping procedure table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign notify miragen writing that proposed target includes excluded target which case miragen shall have right verify such determination forth below table style margin margin bottom margin left font size font family time roman santaris notify miragen pursuant section nbsp nbsp within such period then proposed target shall deemed have passed gate keeping procedure style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign santaris notifies miragen writing that proposed target includes excluded target then upon miragen request within thereafter santaris shall promptly submit mutually agreed independent third party auditor sufficient documentation such third party auditor verify that proposed target includes excluded target such third party auditor shall disclose miragen within table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign receiving such documentation from santaris only whether proposed target includes excluded target result such verification procedure such third party auditor shall deemed confidential information santaris miragen shall bear cost such third party auditor such auditor find that proposed target includes excluded target santaris shall bear cost such third party auditor such auditor find that proposed target include excluded target such auditor find that proposed target include excluded target miragen request such verification then proposed target shall deemed have passed gate keeping procedure such auditor find that proposed target includes excluded target then proposed target shall deemed have failed gate keeping procedure table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign excluded target mean proposed miragen target existing target target replacement existing target which nbsp prior date miragen nomination santaris entered into agreement with third party that time miragen nomination prevents santaris from granting exclusive license develop commercialize compound targeting such target provided section nbsp nbsp prior date miragen nomination santaris commenced bona fide internal research development program directed against such target program still ongoing time miragen nomination nbsp with respect target other than prior date miragen nomination nbsp santaris either nbsp entered into agreement with third party that when such agreement force prevented santaris from granting exclusive license develop commercialize compound targeting such target provided section nbsp time miragen nomination such third party agreement been terminated otherwise longer prevents santaris from granting such exclusive license nbsp commenced bona fide internal research development program directed against such target time miragen nomination program been suspended halted nbsp patent claiming compound targeting such target filed santaris third party licensee time miragen nomination nbsp such patent still includes least claim that claim more compound targeting such target nbsp such patent still pending patent application issued unexpired patent that been dedicated public disclaimed abandoned held unenforceable invalid court other government authority competent jurisdiction unappealed unappealable decision nbsp least have been completed such compound santaris third party licensee table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign miragen nominates miragen target target that described clause nbsp also described clause nbsp nbsp subsection santaris shall notify miragen such status such nominated target previously subject exclusive license granted santaris third party such third party develop commercialize compound targeting such target time miragen nomination such license agreement been terminated santaris payment obligation such former exclusive licensee account practice santaris technology exclusively licensed santaris such former exclusive licensee such santaris technology reverted technology then santaris shall within after receipt applicable target notice disclose writing miragen scope content reverted technology santaris payment obligation with respect practice such reverted technology development commercialization compound targeting such target santaris then elect discretion allow such nominated target miragen target then party shall negotiate good faith reach agreement commercially reasonable term condition include such target miragen target including miragen elect obtain right reverted technology obligation miragen make payment such third party obtain such right party have reached such agreement within after santaris notifies miragen willingness allow such nominated target miragen target such nominated target shall become miragen target table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign research diligence respect each exclusive research license miragen shall diligent effort either directly subject term section nbsp through more sublicensees discover research miragen compound conduct clinical development product target prior acceptance product targeting such target under such exclusive research license including maintaining utilizing sufficient resource facility perform such activity using personnel with sufficient skill experience such number reasonably required accomplish efficiently expeditiously objective under such exclusive research license good scientific manner compliance material respect with applicable santaris sole remedy with respect breach diligence obligation forth this section nbsp shall termination exclusive research license granted miragen with immediate effect with respect existing target which miragen breached diligence obligation forth this section nbsp accordance with section nbsp other applicable effect such termination forth referred section nbsp party acknowledge agree that miragen used diligent effort compliance with this section nbsp restatement date table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign joint research committee within following effective date santaris miragen shall establish joint research committee assist miragen effort research develop product hereunder shall serve primarily forum facilitate communication between party enable santaris provide miragen such technical assistance expertise party desire form consultation advice pursuant section nbsp table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign connection with miragen research early development activity including other similar activity relating miragen compound product shall comprised representative from each party appointed such party party replace more representative from time time upon written notice other party until termination this agreement december nbsp whichever come first shall meet least once each quarter date time location mutually agreed unless party mutually agree different meeting frequency shall have authority decide matter arising hereunder behalf either party table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign technical support santaris shall make scientific personnel reasonably available miragen connection with meeting otherwise including telephone email method that requires travel such purpose table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign table style margin margin bottom margin left font size font family time roman santaris shall required provide consultation other service pursuant this section nbsp after earlier nbsp anniversary restatement date nbsp date which miragen santaris change control becomes effective provided that absence miragen change control santaris shall share with miragen during term this agreement know controlled santaris that relates toxicology manufacture obtaining regulatory approval compound santaris identifies sole discretion such know useful miragen research development commercialization effort pursuant this agreement notwithstanding anything otherwise contrary hereunder santaris shall required perform research development activity connection with miragen target miragen compound product behalf miragen affiliate sublicensees transfer miragen affiliate sublicensees material connection with activity contemplated pursuant this section nbsp style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign research report until termination this agreement miragen provision report pursuant section nbsp with respect existing target whichever come first miragen shall provide least five business advance each meeting reasonably detailed written progress report status research activity with respect each existing target which exclusive research license terminated including summary data result generated with respect such target assessment likelihood timetable completion applicable enabling study filing inds with respect such target each such report shall deemed confidential information miragen clarity miragen shall have obligation provide report research activity conducted under exclusive research license table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign miragen hereby acknowledges agrees that nbsp assumes sole responsibility designating target nbsp neither santaris affiliate make representation warranty table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign product development commercialization table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign product license option miragen shall have option obtain product license each target provided below product license option table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign prior commencing enabling study compound targeting target other than existing target miragen exercise right obtain product license respect such target member target written notice santaris party shall follow gate keeping procedure forth section nbsp within after such proposed target each member target pass gate keeping procedure miragen shall amount required under section nbsp such target target member shall then target target shall then target table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign within after effective date miragen shall propose target member target included product license written notice santaris party shall follow gate keeping procedure forth section nbsp such proposed target member target pass such gate keeping procedure such target member target shall designated target such proposed target member target fails such gate keeping procedure miragen shall have right propose alternative target until proposed target member target pass gate keeping procedure thereby designated target table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign there shall more than target particular time point clarity target replaced under section nbsp such replaced target shall longer target shall counted toward total number target miragen shall have right propose target excluding replacement target which proposed during time period forth section nbsp after anniversary restatement date table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign clarity miragen product license under section nbsp target will cover target that nominated miragen target fails gate keeping procedure forth section nbsp other target other than existing target which miragen seek nominate target compound targeting such target identified practice exclusive research license table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign miragen acknowledges that nothing this agreement shall restrict santaris itself through affiliate third party from discovering researching developing commercializing compound targeting target that existing target target table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign product license subject term section nbsp santaris hereby grant miragen exclusive license under platform technology santaris technology research other than discover develop commercialize product territory field product license clarity product license target that subject gate keeping procedure section nbsp shall become effective unless until such target passed such gate keeping procedure miragen applicable amount under section nbsp miragen grant affiliate third party sublicense under product license with right grant additional sublicenses provided that each such sublicense shall table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign written agreement subject subordinate consistent with term condition this agreement that applicable such sublicense table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign require each such sublicensee comply with applicable term this agreement including keeping book record with respect sale product such sublicensee permitting santaris audit through independent auditor consistent with section nbsp such book record sole purpose verifying sale based payment required paid miragen pursuant section indemnifying santaris same manner provided section nbsp with respect activity performed such sublicensee table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign diminish reduce eliminate miragen obligation under this agreement including obligation diligent effort develop commercialize product effort sublicensee such regard shall considered effort miragen table style margin margin bottom margin left font size font family time roman miragen shall remain primarily responsible obligation hereunder performance sublicensees shall guarantee that such sublicensees comply with relevant provision this agreement miragen shall provide santaris copy each such sublicense agreement which redacted confidential information reasonably required santaris verify that such agreement complies with this section nbsp provided that miragen shall redact trigger milestone other payment under such sublicense agreement which will qualify upfront payment sublicense revenue upon receipt miragen redact amount each such payment which amount shall disclosed santaris when miragen receives such payment obligated make payment under section nbsp result such receipt style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign exclusivity table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign santaris exclusivity long this agreement expired been terminated with respect particular target santaris affiliate shall either their benefit behalf third party shall grant maintain grant right third party nbsp miragen target such target nbsp miragen target such target that miragen target nbsp miragen target such target that miragen target wherein table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign miragen exclusivity neither miragen affiliate sublicensees shall directly indirectly until nbsp nbsp whichever occurs first table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign product development semi annual update miragen shall diligent effort develop obtain regulatory approval including marketing approval commercialization except provided section nbsp commercialize least product target pursuant product license such target miragen shall provide santaris semi annual written report regarding product research development activity upon request santaris shall meet with santaris review such product research development activity reasonable time location least twice during each year term table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign regulatory approval between party miragen shall file name name affiliate sublicensee application regulatory approval product between party miragen shall have sole responsibility communicating with regulatory authority regarding application regulatory approval regulatory approval once granted table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign regulatory reporting between party miragen shall responsible filing report required filed order maintain regulatory approval granted product territory provided however between party miragen shall solely responsible adverse drug experience report literature review associated report adverse drug experience font style white space nowrap follow font report preparation submission safety report regulatory authority required maintaining global safety database interaction with regulatory authority periodic submission labeling modification risk management safety monitoring detection safety measure clinical hold restriction distribution table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign commercialization miragen shall diligent effort commercialize each product each country which miragen obtained marketing approval upon santaris written request exceed once annually miragen shall provide summary miragen affiliate sublicensees major marketing promotional sale activity result performing marketing promotion activity respect product miragen affiliate sublicensees shall comply with applicable regulation guideline concerning such promotional activity table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign consideration table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign cash consideration paid prior restatement date party acknowledge that miragen paid santaris prior restatement date connection with execution first amendment original agreement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign additional upfront cash consideration within after restatement date miragen shall table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign existing target within after restatement date miragen shall euro respect right granted existing target table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign target replacement within after notice from santaris that proposed replacement target member target accepted existing target pursuant term forth section nbsp miragen shall provided that payment shall under this section nbsp nbsp nbsp clarity shall considered table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign product license option within after exercise product license option proposed target notice from santaris that such target accepted target pursuant section nbsp miragen shall provided that payment shall under this section nbsp target table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign equity miragen issued santaris share share miragen series preferred stock value share series preferred stock which such share were issued accordance with equity agreement party amending equity agreement date hereof provide immediate vesting share table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign milestone payment table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign subject section product product basis only once each product miragen shall santaris amount forth below within after achievement corresponding milestone event miragen affiliate table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width style font family time roman font size valign bottom nowrap style margin margin bottom border bottom solid width font size font family time roman milestone event valign bottom nbsp nbsp valign bottom align center style border bottom solid amount nbsp bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign clarity milestone payment shall made twice same product purpose determining whether milestone payment triggered under this section nbsp product containing miragen compound single active ingredient combination product comprising same miragen compound other miragen compound developed pursuant that separate from first miragen compound such product shall deemed same product regardless dosage formulation route administration product indication intended label other active ingredient contained therein table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign this section nbsp shall longer apply respect particular milestone event particular product corresponding milestone payment under this section nbsp shall triggered time such milestone event achieved such product miragen affiliate granted sublicensee other than affiliate miragen sublicense develop commercialize such product least united state entire european union time such milestone event achieved such product miragen affiliate granted more sublicensees other than affiliate miragen sublicenses develop commercialize such product none such sublicenses include united state entire european union then miragen shall santaris greater nbsp milestone payment under this section nbsp achievement such milestone event such product nbsp santaris share pursuant section nbsp sublicense revenue received miragen from such sublicensees account achievement such milestone event such product table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign payment payment under this article refundable creditable shall paid immediately available fund bank account designated santaris table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign royalty duration royalty period product product country country basis miragen shall santaris royalty equal nbsp sale such product such country miragen affiliate table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign nbsp sale such product such country sublicensees nbsp sublicense royalty received miragen affiliate sale such product such country sublicensees than such sale except that sublicense royalty received miragen affiliate account such sale after deduction miragen third party payment obligation with respect thereto than such sale then royalty shall owed santaris with respect such sale after royalty period product country territory further royalty shall payable respect sale such product such country thereafter product license with respect such product such country shall fully paid perpetual irrevocable royalty free exclusive license table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign sharing upfront payment sublicense revenue respect each miragen target which product license becomes effective miragen shall santaris nbsp upfront payment nbsp subject section nbsp sublicense revenue clarity excluding sublicense royalty that each case miragen receives from sublicensee table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign report payment table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign royalty statement payment during royalty period particular product particular country within after each calendar quarter miragen shall deliver santaris report setting forth such calendar quarter following information product product country country basis nbsp sale such product such country during such calendar quarter nbsp basis adjustment royalty payable such sale such product such country nbsp royalty hereunder sale such product such country nbsp currency exchange rate used determining such royalty nbsp amount sublicense revenue received miragen affiliate such product such country during such calendar quarter such report shall product until first commercial sale such product territory miragen granted sublicense hereunder whichever earlier total royalty share sublicense revenue sale product during such quarter shall remitted time such report made table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign withholding payment under this agreement shall made full without deduction withholding account unless such deduction withholding required applicable regulation miragen required deduct withhold miragen will nbsp promptly notify santaris such requirement nbsp relevant authority full amount required deducted withheld promptly upon earlier determining that such deduction withholding required receiving notice that such amount been assessed against santaris reduce payment santaris same amount nbsp promptly forward santaris official receipt certified table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign copy other documentation reasonably acceptable santaris evidencing such payment such authority nbsp cooperate reasonably santaris request santaris expense effort santaris obtain refund otherwise recover such withheld table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign currency except expressly indicated otherwise amount payable calculation hereunder shall united state dollar applicable sale sublicense revenue sublicense royalty royalty deduction shall converted into united state dollar accordance with miragen customary usual conversion procedure consistently applied table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign blocked currency time legal restriction prevent prompt remittance part royalty with respect country where product sold payment shall made through such lawful mean method party mutually determine table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign interest late payment amount paid within after date under this agreement subject interest from date through including date upon which payment received such interest shall calculated rate equal percentage point over london interbank offered rate such rate published wall street journal successor thereto last business applicable quarter prior date which such payment maximum rate permitted whichever table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign maintenance record audit table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign record keeping miragen affiliate shall keep shall cause sublicensees keep accurate book account record connection with sale product sufficient detail permit accurate determination figure necessary verification payment paid hereunder miragen affiliate sublicensees shall maintain such record period least year after year which they were generated table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign audit upon prior written notice from santaris miragen shall permit independent certified public accounting firm internationally recognized standing selected santaris reasonably acceptable miragen examine santaris sole expense relevant book record miragen reasonably necessary verify accuracy report submitted miragen accordance with section nbsp payment royalty amount payable under section nbsp examination santaris under this section nbsp shall occur more than year shall limited pertinent book record which have previously been examined under this section nbsp santaris year ending more than year before table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign date request accounting firm shall provided access such book record miragen facility where such book record normally kept such examination shall conducted during miragen normal business hour miragen shall require sublicensees grant miragen santaris independent auditor approved such sublicensee santaris have comparable access such sublicensees relevant book record verify payment royalty party independent auditor engaged party conduct audit sublicensee pursuant preceding sentence such party shall share result such audit confidence with other party table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign underpayment overpayment such accounting firm concludes that additional royalty share sublicense revenue were santaris miragen shall santaris additional royalty within date miragen receives such accountant written report concluding such underpayment exceeds royalty share sublicense revenue that were paid santaris miragen also shall reimburse santaris reasonable charge such accountant conducting audit such accounting firm concludes that miragen overpaid royalty share sublicense revenue santaris miragen shall entitled reduce subsequent payment amount overpayment table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign intellectual property table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign ownership table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign between party miragen shall sole exclusive owner right title interest miragen compound patent table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign subject section nbsp between party each party shall invention other know conceived reduced practice otherwise made solely employee such party patent claiming such invention table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign subject section nbsp invention other know conceived reduced practice otherwise made jointly employee both party connection with activity performed under this agreement such invention know patent claiming such invention collectively joint shall jointly owned party each party exploit joint without accounting obtaining consent from other party subject right obligation party with respect joint under this agreement including miragen research license product license right granted santaris under section nbsp including schedule party shall discus good faith term condition upon which prosecution maintenance enforcement patent within joint shall conducted allocated between party table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign inventorship determination inventorship under this agreement shall made accordance with patent united state table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign improvement platform technology table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign patent prosecution maintenance table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign enforcement patent table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign patent table style margin margin bottom margin left text indent font size font family time roman restatement date santaris conducting bona fide internal program develop compound targeting also referred connection with such program santaris planning assign patent affiliate that time such assignment will wholly owned subsidiary santaris that subsequently become third party result investment sale more third party such assignee patent assignee santaris hereby covenant miragen that connection with assignment patent santaris shall obtain from assignee shall maintain during remainder term after such assignment style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign exclusive license with right grant sublicenses under patent research develop commercialize compound that claimed patent that targeting target other than target territory field table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign right cause assignee extent possible practicable likely have adverse effect patentability validity enforceability patent file divisional patent application separate claim covering compound targeting from claim that cover only compound targeting target table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign right cause assignee assign santaris right title interest each divisional patent application that claim compound targeting patent issuing from such divisional patent application collectively divisional patent table style margin margin bottom margin left text indent font size font family time roman miragen shall have right with respect patent except forth this section nbsp section nbsp below santaris shall shall ensure that affiliate assignee future assignee licensee patent shall assert against miragen affiliate patent that claim compound targeting target with respect miragen affiliate discovery identification clinical research development performance clinical research clinical development immediately prior commencement enabling study compound targeting such target provided that such target passed screening procedure forth section nbsp clarity foregoing covenant pertain compound targeting because blocked target capable passing screening procedure forth section nbsp style margin margin bottom margin left text indent font size font family time roman event that miragen nominates target miragen target whether existing target target replacement existing target target product license such target pass gate keeping procedure section nbsp such that such target becomes miragen target then style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidentiality table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign confidentiality except extent expressly authorized this agreement otherwise agreed writing party party agree that each party receiving party receiving confidential information other party disclosing party shall keep such confidential information confidential shall publish otherwise disclose such confidential information purpose other than exercise right perform obligation under this agreement provided that such disclosure nbsp limited need know basis those person directly involved performing relevant activity permitted under this agreement require access such confidential information legal representative nbsp subject confidentiality obligation restrictive than those forth herein table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign confidential information shall include information that receiving party establish table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign already known receiving party other than under obligation confidentiality time disclosure disclosing party such receiving party documentary evidence that effect table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign generally available public otherwise part public domain time disclosure receiving party table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign became generally available public otherwise part public domain after disclosure receiving party other than through omission receiving party breach confidentiality obligation forth this article table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign disclosed receiving party other than under obligation confidentiality third party obligation disclosing party disclose such information others table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign independently discovered developed behalf receiving party without reference confidential information other party receiving party documentary evidence that effect table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign authorized disclosure notwithstanding section nbsp receiving party disclose confidential information disclosing party extent such disclosure reasonably necessary table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign file prosecute patent application which receiving party authorized file prosecute hereunder table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign facilitate discussion with actual potential collaborator investor acquirer connection with collaboration with investment acquisition receiving party subject confidentiality obligation restrictive than those forth herein with shorter duration appropriate event period that shorter than year from date disclosure receiving party such person entity table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign extent necessary comply with applicable regulation applicable governmental authority including connection with filing obtaining maintaining regulatory approval table style margin margin bottom margin left font size font family time roman event that receiving party shall deem necessary disclose pursuant this section nbsp confidential information disclosing party receiving party shall extent possible give reasonable advance notice such disclosure disclosing party take reasonable measure ensure confidential treatment such information style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign similar filing either party disclose term this agreement extent required reasonable opinion such party legal counsel comply with applicable rule regulation including rule regulation promulgated united state security exchange commission copenhagen stock exchange other applicable regulatory organization self regulatory organization notwithstanding foregoing before disclosing this agreement term hereof pursuant this section nbsp party will consult with another term this agreement redacted making such disclosure party discloses this agreement term hereof accordance with this section nbsp such party agrees expense seek confidential treatment portion this agreement such term reasonably requested other party table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign public announcement publication table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign coordination santaris miragen shall from time time request other party discus agree general information content relating this agreement that publicly disclosed including mean printed publication oral presentation provided that miragen subject section nbsp section nbsp shall have obligation consult with santaris with respect scientific publication public announcement concerning development manufacturing commercialization activity with respect miragen compound product under this agreement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign announcement except expressly permitted under section nbsp appropriate miragen make connection with development commercialization activity contemplated hereunder neither party will make public announcement regarding this agreement development commercialization miragen compound product without prior written approval other party sake clarity nothing this agreement shall prevent miragen from making scientific publication public announcement concerning development commercialization activity with respect miragen compound product under this agreement provided that miragen shall disclose confidential information santaris such publication announcement without obtaining santaris prior written consent table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign termination prior confidentiality agreement this agreement supersedes confidentiality agreement between party dated prior effective date collectively prior confidentiality agreement including amendment thereto provided that foregoing shall limit remedy available either party with respect breach prior confidentiality agreement which occurred prior effective date information defined prior confidentiality agreement exchanged between party under prior confidentiality agreement shall deemed confidential information under this agreement shall subject term this article table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign representation table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign representation covenant each party each santaris miragen hereby represents covenant other party follows effective date restatement date table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign corporation entity duly organized validly existing under state other jurisdiction incorporation formation table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign execution delivery performance this agreement such party been duly authorized requisite corporate action table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign power authority execute deliver this agreement perform obligation hereunder table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign this agreement legal valid obligation binding upon enforceable accordance with term subject applicable limitation enforcement based bankruptcy other debtor right table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign execution delivery performance such party this agreement compliance with term provision hereof will conflict with result breach term provision constitute default under nbsp loan agreement guaranty financing agreement agreement affecting product other agreement instrument binding affecting property nbsp provision charter other governing document bylaw nbsp order writ injunction decree court governmental authority entered against which property bound table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign shall time comply material respect with applicable regulation relating activity under this agreement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign entered into after effective date shall enter into oral written agreement arrangement that would inconsistent with obligation under this agreement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign additional santaris representation except extent disclosed santaris pursuant letter miragen dated effective date santaris further represents covenant miragen follows that table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign santaris effective date restatement date will following effective date knowingly nbsp grant right that inconsistent with right granted miragen herein nbsp take action that would prevent from granting right granted miragen under this agreement that would otherwise materially conflict with adversely affect miragen right under this agreement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign effective date restatement date there action suit proceeding investigation pending against santaris before court government regulatory body agency commission official arbitrator that reasonably expected have material adverse effect santaris ability consummate transaction contemplated hereby table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign effective date restatement date nbsp santaris solely owns identified schedule exclusive licensee good standing platform technology existence effective date restatement date applicable nbsp assignee solely owns patent existence restatement date table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign effective date restatement date santaris received aware claim allegation that third party other than third party licensor identified schedule right interest patent patent platform technology santaris technology that such patent invalid unenforceable table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign effective date restatement date santaris filed claim sent notice third party claiming that activity such third party have infringed misappropriated platform technology santaris technology santaris knowledge third party infringing misappropriating platform technology santaris technology case pending claim evaluating them issued each case extent relating miragen target table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign effective date restatement date santaris received aware claim allegation that practice platform technology infringes misappropriates intellectual property right third party table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign santaris hereby further represents warrant miragen that table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign unless particular target been selected santaris licensee license from santaris under platform technology development beyond commencement enabling study commercialization product directed such target before miragen submits such target target gate keeping procedure forth section nbsp santaris agreement with santaris licensee permit santaris grant right miragen such target part existing target target subject santaris licensee exclusive license described clause nbsp research including enabling study table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign product license existing target target connection with clinical development activity performed after commencement enabling study clinical development activity commercialization table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign activity shall exclusive even with respect santaris licensee reliance such representation warranty miragen acknowledges that solely with respect existing target target target replacing miragen target pursuant section nbsp miragen exclusive research license product license santaris obligation under section nbsp each case connection with discovery research activity conducted prior commencement enabling study subject exclusive license granted santaris santaris licensee described above clause table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign disclaimer except otherwise expressly forth herein party make representation extend warranty kind either express implied particularly that target free patent other intellectual property right third party that product will successfully developed hereunder product developed with respect such product party disclaim implied warranty title infringement merchantability fitness particular purpose table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign term termination table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign term term this agreement will commence effective date shall extend unless this agreement terminated earlier accordance with this article until nbsp there least miragen target that been terminated expiration royalty period nbsp termination last miragen target including replacement target provided that miragen right pursuant section nbsp obtain product license target expired prior such termination nbsp expiration miragen right pursuant section nbsp obtain product license target provided that miragen target including their replacement target were terminated before such expiration term table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign termination either party material breach other party table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign either party terminate this agreement target target basis time giving written notice other party other party commits material breach obligation under this agreement with respect particular target such breach remains uncured case breach payment obligation from date written notice such breach which notice shall identify relevant target given breaching party additionally miragen fails cure deemed material breach under penultimate sentence section nbsp within cure period referred therein santaris terminate this agreement with respect more miragen target upon written notice miragen without additional cure period table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign either party terminate this agreement entirety time giving written notice other party other party commits material breach obligation under this agreement that directed only particular target such breach remains uncured case breach payment obligation from date written notice such breach given breaching party table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign each party terminate this agreement with immediate effect upon providing other party with written notice other party breach section nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign termination insolvency this agreement terminated entirety with immediate effect santaris upon written notice miragen nbsp case commenced against miragen under applicable bankruptcy insolvency similar dismissed within thereafter nbsp miragen file subject institution bankruptcy reorganization liquidation receivership similar proceeding that dismissed within thereafter nbsp miragen assigns substantial portion asset benefit creditor nbsp receiver custodian appointed miragen business dismissed within after appointment nbsp substantial portion miragen business subject attachment similar process which attachment similar process dismissed within thereafter nbsp miragen suspends making payment with respect class debt period more than nbsp anything analogous event described foregoing subsection nbsp through nbsp occurs under applicable jurisdiction addressed corrected within table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign termination will miragen miragen terminate this agreement entirety target target basis reason time upon prior written notice santaris table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign effect termination table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign effect termination miragen material breach santaris miragen terminates this agreement with respect target pursuant section nbsp then right obligation each party under this agreement shall terminate with respect such target agreement entirety case subject section nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign effect termination target terminated miragen will replaced miragen terminated santaris miragen material breach insolvency table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign miragen give notice termination more miragen target target pursuant section nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign miragen replaces more miragen target target pursuant section nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign santaris terminates more miragen target target pursuant section table style margin margin bottom margin left font size font family time roman then each case upon effective date such termination provision schedule shall apply style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign santaris agrees that this agreement terminated santaris pursuant section nbsp such termination arise directly indirectly from omission particular sublicensee santaris will such sublicensee request enter into agreement direct license with such sublicensee whereby such sublicensee would receive table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign with respect right granted santaris miragen under this agreement sublicensed such sublicensee miragen under sublicense substitute sublicense from miragen which sublicense terminated result termination this agreement direct license from santaris same scope such sublicense table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign with respect right licensed santaris from miragen pursuant schedule upon such termination direct sublicense from santaris same scope such sublicensee license with respect thereto under sublicense with miragen such sublicensee would retain with respect thereto patent prosecution enforcement right forth sublicense with miragen table style margin margin bottom margin left font size font family time roman such sublicensee request direct license from santaris such sublicensee shall required result such termination this agreement with respect miragen grant santaris license forth schedule respect miragen compound patent miragen product technology controlled such sublicensee direct license shall same term condition that applied miragen under this agreement including term with respect termination effect thereof provided that santaris shall receive from such sublicensee same financial payment that santaris would have otherwise received from miragen under section nbsp nbsp this agreement this agreement been terminated with respect miragen such sublicensee remained sublicensee clarity direct license shall require such sublicensee santaris amount that miragen would have been required santaris pursuant section nbsp style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign effect termination exclusive research license this agreement terminated entirety reason before expiration exclusive research license exclusive research license shall terminate addition other effect under this section table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign pending dispute resolution party give notice termination under section nbsp other party dispute whether such notice proper then issue whether this agreement been terminated entirety with respect only more target shall resolved accordance with article each party shall continue perform obligation hereunder pending conclusion such dispute resolution proceeding result such dispute resolution process determined that notice termination proper then such termination shall become effective breach cured within applicable such determination subject section nbsp breaching party shall remain liable damage accrued during dispute resolution proceeding described this section nbsp result such dispute resolution proceeding determined that notice termination improper then termination shall have occurred this agreement shall remain effect table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign survival certain obligation expiration termination this agreement shall relieve either party obligation including payment obligation that accrued before effective date such expiration termination nothing section nbsp this article shall deemed limit party from other remedy that such party have material breach this agreement other party right obligation party with respect target terminated hereunder shall remain full force effect remainder term following provision shall survive expiration termination this agreement section last sentence only solely respect activity conducted product sold prior termination last sentence solely with respect royalty period that have expired prior termination this agreement expiration agreement solely respect royalty other amount accrued hereunder prior termination including schedule article provided that section nbsp shall survive solely with respect announcement termination expiration this agreement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign indemnification insurance table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign indemnification miragen miragen shall indemnify defend santaris affiliate licensors assignor each their respective employee officer director agent each santaris indemnified party from table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign against liability loss damage expense including reasonable attorney expense cost collectively liability that santaris indemnified party incurs suffers resulting from arising third party claim arising table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign practice research license development commercialization miragen compound product behalf under authority miragen affiliate sublicensees including patent infringement clarity including infringement target patent personal injury death person result miragen compound product table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign miragen representation forth herein being untrue when made table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign breach miragen covenant under this agreement table style margin margin bottom margin left font size font family time roman except each case extent caused nbsp gross negligence willful misconduct santaris santaris indemnified party nbsp santaris representation forth herein being untrue when made nbsp breach santaris covenant under this agreement style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign indemnification santaris santaris shall indemnify defend miragen affiliate each their respective employee officer director agent each miragen indemnified party from against liability that miragen indemnified party incurs suffers resulting from arising third party claim arising table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign table style margin margin bottom margin left font size font family time roman except each case extent caused nbsp gross negligence willful misconduct miragen miragen indemnified party nbsp miragen representation forth herein being untrue when made nbsp breach miragen covenant under this agreement style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign procedure each party will notify other promptly event becomes aware claim which indemnification sought hereunder furtherance limitation preceding sentence case proceeding including governmental investigation shall instituted involving party respect which indemnity sought pursuant this article such party indemnified party shall promptly notify other party indemnifying party writing within after indemnified party first becomes aware such proceeding party shall promptly meet table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign discus respond claim that subject matter such proceeding indemnifying party shall have right assume defense claim asserted third party subject indemnification obligation hereunder indemnifying party upon assuming defense such claim shall retain counsel reasonably satisfactory indemnified party conduct defense such claim shall expense such counsel indemnified party shall cooperate fully with indemnifying party defense such claim proceeding such proceeding indemnified party shall have right retain counsel expense such counsel shall expense indemnified party unless named party such proceeding including impleaded party include both indemnifying party indemnified party representation both such party same counsel would inappropriate actual potential differing interest between them indemnifying party shall liable settlement proceeding effected without written consent settled with such consent there final judgment plaintiff indemnifying party agrees indemnify indemnified party from against loss liability reason such settlement judgment indemnifying party shall without written consent indemnified party effect settlement pending threatened proceeding respect which indemnified party arising same fact could have been party indemnity could have been sought hereunder indemnified party unless such settlement includes unconditional release indemnified party from liability claim that subject matter such proceeding table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign insurance miragen shall obtain maintain commercial general liability insurance with reputable financially secure insurance carrier cover indemnification obligation under section nbsp with limit than occurrence aggregate after miragen commencement human clinical trial with limit than occurrence aggregate such insurance shall procured with carrier having best rating better table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign liability except with respect liability arising from breach article extent such party required indemnify other party under this article neither party respective affiliate shall liable other party special punitive consequential damage whether based contract tort arising under applicable otherwise connection with this agreement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign dispute resolution table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign executive mediation party shall first seek resolve controversy claim dispute arising relating this agreement through good faith discussion party unable resolve such dispute course such discussion matter shall referred party respective executive table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign officer resolved negotiation good faith soon practicable event later than after referral executive officer resolve such dispute within such period either party initiate dispute resolution procedure forth section nbsp discussion negotiation between party pursuant this section nbsp shall admissible subsequent dispute resolution proceeding purpose this article executive officer mean president miragen executive officer miragen designated such president miragen chief executive officer santaris executive officer santaris designated such chief executive officer santaris avoidance doubt controversy claim dispute arising relating this agreement referred binding arbitration under section nbsp until party have followed executive mediation procedure forth this section nbsp provided however neither party shall required follow executive mediation procedure forth this section nbsp before attempting obtain temporary restraining order preliminary injunction other interim conservatory relief table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign arbitration table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign dispute resolved negotiation executive officer forth section nbsp party agree resolve such dispute through final binding arbitration conducted under time following period negotiation between executive officer forth section nbsp either party initiate arbitration unresolved dispute written notice other party intention arbitrate which notice shall specify reasonable detail nature dispute table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign arbitration shall conducted panel three person provided that dispute involves claim damage than there shall only arbitrator nominated jointly party within such arbitration notice within after initiation arbitration each party shall nominate person arbitrator party selected arbitrator shall jointly nominate third arbitrator within their appointment arbitrator nominated within these time period arbitrator nominated party under this section nbsp approved appointment shall appoint suitable replacement arbitrator shall independent expert including lawyer with least year experience with intellectual property licensing agreement pharmaceutical industry shall have been affiliate sublicensee employee consultant officer director stockholder either party shall comply with requirement guideline conflict interest international arbitration chair tribunal shall have same nationality either party table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign arbitration proceeding shall conducted arbitration proceeding pleading written evidence shall english language written evidence originally another language shall submitted english translation accompanied original true copy thereof table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign each party agrees reasonable effort make current employee available testify provide written statement reasonably necessary addition authority conferred upon arbitral tribunal rule arbitral tribunal shall have authority order production document accordance with rule taking evidence international arbitration table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign arbitrator shall have power decide question arbitrability arbitrator shall instructed required render nbsp draft resolution award within conclusion taking evidence party provide comment thereon within after receipt nbsp final written resolution award each issue that clearly state basis upon which such resolution award made final written resolution award shall delivered party expeditiously possible event more than after conclusion taking evidence table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign confirmation judgment upon award rendered tribunal entered competent court application made competent court judicial acceptance such award order enforcement each party agrees that notwithstanding provision applicable this agreement shall request arbitrator shall have authority award punitive exemplary damage against party party apply court competent jurisdiction temporary restraining order preliminary injunction other interim conservatory relief necessary without breaching these arbitration provision without abridging power arbitrator table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign except extent necessary confirm obtain judgment award decision required applicable neither party party shall instruct arbitrator disclose existence content result arbitration without prior written consent both party table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign party agree that nbsp nbsp payment made party pursuant decision tribunal shall made united state dollar without deduction made obligation other deduction table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign miscellaneous table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign assignment change control table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign assignment neither this agreement interest hereunder shall assignable obligation hereunder shall delegated either party without prior written consent other party which consent shall unreasonably withheld delayed provided that santaris shall have right assign right receive cash payment under article third party upon prior written notice miragen notwithstanding foregoing subject subsection nbsp nbsp below each party without other party consent assign entire interest this agreement nbsp affiliate such assigning party long such person entity remains affiliate such assigning party nbsp successor substantially asset whether acquisition merger sale stock sale asset other transaction provided that case assignment affiliate assigning party shall guarantee performance this agreement such affiliate this agreement shall binding upon successor permitted assigns party assignment accordance with this section nbsp shall void table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign miragen change control upon miragen change control milestone payment referred item nbsp nbsp table forth section nbsp that have been achieved miragen affiliate before such miragen change control shall increased amount forth such section table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign santaris change control upon santaris change control table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign milestone payment referred item nbsp nbsp table forth section nbsp that have been achieved miragen affiliate before such santaris change control shall decreased amount forth such section table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign santaris shall have right miragen shall have obligation under schedule respect target that becomes terminated miragen target after such santaris change control table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign implied right except expressly provided this agreement neither party shall deemed estoppel implication otherwise have granted other party license other right with respect intellectual property such party table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign further action each party agrees execute acknowledge deliver such further instrument such other necessary appropriate order carry purpose intent this agreement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign force majeure neither party shall liable other delay failure performance obligation part contained this agreement extent that such failure delay circumstance beyond control could have avoided exercise reasonable diligence shall notify other party promptly should such circumstance arise giving indication likely extent duration thereof shall diligent effort resume performance obligation soon practicable provided that neither party shall required settle labor dispute disturbance table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign notice notice notification required permitted provided under this agreement shall writing shall deemed given delivered personally facsimile transmission receipt verified five after deposited mail mailed certified mail return receipt requested postage prepaid third business sent internationally recognized express courier service party following address facsimile number such other address facsimile number party shall specified like notice provided that notice change address facsimile number shall effective only upon receipt thereof table style margin margin bottom margin left font size font family time roman correspondence miragen shall addressed follows style margin margin bottom margin left font size font family time roman miragen therapeutic style margin margin bottom margin left font size font family time roman lookout road style margin margin bottom margin left font size font family time roman suite style margin margin bottom margin left font size font family time roman boulder style margin margin bottom margin left font size font family time roman united state america style margin margin bottom margin left font size font family time roman attn william marshall style margin margin bottom margin left font size font family time roman nbsp style margin margin bottom margin left font size font family time roman with copy style margin margin bottom margin left font size font family time roman cooley style margin margin bottom margin left font size font family time roman five palo alto square style margin margin bottom margin left font size font family time roman camino real style margin margin bottom margin left font size font family time roman palo alto style margin margin bottom margin left font size font family time roman united state america style margin margin bottom margin left font size font family time roman attention marya postner style margin margin bottom margin left font size font family time roman facsimile nbsp style margin margin bottom margin left font size font family time roman correspondence santaris shall addressed follows style margin margin bottom margin left font size font family time roman santaris pharma style margin margin bottom margin left font size font family time roman kogle eacute style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom margin left font size font family time roman oslash rsholm style margin margin bottom margin left font size font family time roman denmark style margin margin bottom margin left font size font family time roman attn chief executive officer style margin margin bottom margin left font size font family time roman style margin margin bottom margin left font size font family time roman with copy style margin margin bottom margin left font size font family time roman santaris pharma style margin margin bottom margin left font size font family time roman kogle eacute style margin margin bottom margin left font size font family time roman oslash rsholm style margin margin bottom margin left font size font family time roman denmark style margin margin bottom margin left font size font family time roman attn chief financial officer style margin margin bottom margin left font size font family time roman style margin margin bottom margin left font size font family time roman style margin margin bottom margin left font size font family time roman santaris pharma style margin margin bottom margin left font size font family time roman kogle eacute style margin margin bottom margin left font size font family time roman oslash rsholm style margin margin bottom margin left font size font family time roman denmark style margin margin bottom margin left font size font family time roman attn general counsel style margin margin bottom margin left font size font family time roman style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign amendment amendment modification supplement provision this agreement shall valid effective unless made writing signed duly authorized officer each party table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign waiver provision agreement shall waived omission knowledge party agent employee except instrument writing expressly waiving such provision signed duly authorized officer waiving party waiver either party breach provision hereof other party shall construed waiver succeeding breach such provision waiver provision itself table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign severability provision this agreement held invalid unenforceable court competent jurisdiction from which appeal taken such provision shall considered severed from this agreement shall serve invalidate remaining provision hereof party shall make good faith effort replace invalid unenforceable provision with valid enforceable such that objective contemplated party when entering into this agreement realized table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign descriptive heading descriptive heading this agreement convenience only shall force effect construing interpreting provision this agreement table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign governing except provided following sentence this agreement shall governed interpreted accordance with substantive without regard conflict principle thereof other than table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign entire agreement party this agreement including schedule equity agreement constitute contain complete final exclusive understanding agreement party respecting subject matter hereof cancel supersedes prior negotiation correspondence understanding agreement whether oral written among party respecting subject matter hereof table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign independent contractor agreed that both party independent contractor under this agreement nothing herein contained shall deemed create employment agency joint venture partnership relationship between party their agent employee other legal arrangement that would impose liability upon party failure other party neither party shall have express implied power enter into contract commitment incur liability name behalf other party bind other party respect whatsoever this agreement shall understood joint research agreement under entered into purpose researching identifying developing miragen compound product table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign counterpart this agreement executed counterpart each which need contain signature more than party such counterpart taken together shall constitute same agreement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign interpretation except where context otherwise requires gender herein shall deemed include other gender singular shall deemed include plural vice versa word used inclusive sense word include includes including shall deemed followed phrase without limitation word will shall construed have same meaning effect word shall unless context requires otherwise nbsp definition reference agreement instrument other document herein shall construed referring such agreement instrument other document from time time amended supplemented otherwise modified subject restriction such amendment supplement modification forth herein nbsp reference herein person shall construed include person successor assigns nbsp word herein hereof hereunder word similar import shall construed refer this agreement entirety particular provision hereof nbsp reference herein article section schedule shall construed refer article section schedule this agreement table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center remainder this page intentionally left blank signature page follows style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman witness whereof duly authorized representative party have duly executed this agreement effective effective date style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size width valign bottom width width valign bottom width width valign bottom width valign bottom width width style font family time roman font size valign colspan miragen therapeutic valign bottom nbsp valign valign bottom nbsp valign colspan santaris pharma style font size height height colspan height colspan height colspan height colspan style font family time roman font size valign valign bottom style border bottom solid nbsp valign style border bottom solid jason leverone valign bottom nbsp valign valign bottom nbsp valign valign bottom style border bottom solid nbsp valign bottom style border bottom solid henrik stage style font family time roman font size valign colspan style margin margin bottom margin left text indent font size font family time roman jason leverone valign bottom nbsp valign valign bottom nbsp valign bottom colspan henrik stage style font family time roman font size valign colspan style margin margin bottom font size font family time roman chief financial officer style margin margin bottom font size font family time roman miragen therapeutic valign bottom nbsp valign valign bottom nbsp valign bottom colspan style margin margin bottom font size font family time roman president chief executive officer style margin margin bottom font size font family time roman santaris pharma table style margin margin bottom font size font family time roman align center small ignature small small small small small small small small mended small small small small estated small small icense small small greement small style margin margin bottom font size font family time roman align center small small small small small between small small iragen small small herapeutics small small small small small small antaris small small harma small style page break before always size style color width align center style margin margin bottom font size font family time roman align center schedule style margin margin bottom font size font family time roman align center platform technology patent existing restatement date style margin margin bottom text indent font size font family time roman style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width valign bottom width width valign bottom width width valign bottom width width valign bottom width width valign bottom width width style font family time roman font size valign bottom nowrap style margin margin bottom border bottom solid width font size font family time roman priority valign bottom nbsp valign bottom align center style border bottom solid style margin margin bottom font size font family time roman align center valign bottom nbsp valign bottom align center style border bottom solid style margin margin bottom font size font family time roman align center europe valign bottom nbsp valign bottom align center style border bottom solid style margin margin bottom font size font family time roman align center canada valign bottom nbsp valign bottom align center style border bottom solid style margin margin bottom font size font family time roman align center japan valign bottom nbsp valign bottom align center style border bottom solid style margin margin bottom font size font family time roman align center australia valign bottom nbsp valign bottom align center style border bottom solid style margin margin bottom font size font family time roman align center rest world bgcolor cceeff style font family time roman font size valign colspan align center style margin margin bottom margin left text indent font size font family time roman align center style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom align right valign bottom nbsp valign bottom align right valign bottom nbsp valign bottom align right valign bottom nbsp valign bottom align right valign bottom nbsp valign bottom align right valign bottom nbsp valign bottom align right bgcolor cceeff style font family time roman font size valign colspan align center style margin margin bottom margin left text indent font size font family time roman align center style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom align right valign bottom nbsp valign bottom align right valign bottom nbsp valign bottom align right valign bottom nbsp valign bottom align right valign bottom nbsp valign bottom align right valign bottom nbsp valign bottom align right bgcolor cceeff style font family time roman font size valign colspan align center style margin margin bottom margin left text indent font size font family time roman align center style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom align right valign bottom nbsp valign bottom align right valign bottom nbsp valign bottom align right valign bottom nbsp valign bottom align right valign bottom nbsp valign bottom align right valign bottom nbsp valign bottom align right table style margin margin bottom text indent font size font family time roman owned santaris style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width valign bottom width width valign bottom width width valign bottom width width valign bottom width width valign bottom width width style font family time roman font size valign bottom nowrap style margin margin bottom border bottom solid width font size font family time roman priority valign bottom nbsp valign bottom align center style border bottom solid style margin margin bottom font size font family time roman align center valign bottom nbsp valign bottom align center style border bottom solid style margin margin bottom font size font family time roman align center europe valign bottom nbsp valign bottom align center style border bottom solid style margin margin bottom font size font family time roman align center canada valign bottom nbsp valign bottom align center style border bottom solid style margin margin bottom font size font family time roman align center japan valign bottom nbsp valign bottom align center style border bottom solid style margin margin bottom font size font family time roman align center australia valign bottom nbsp valign bottom align center style border bottom solid style margin margin bottom font size font family time roman align center rest world bgcolor cceeff style font family time roman font size valign colspan align center style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom align right valign bottom nbsp valign bottom align right valign bottom nbsp valign bottom align right valign bottom nbsp valign bottom align right valign bottom nbsp valign bottom align right valign bottom nbsp valign bottom align right bgcolor cceeff style font family time roman font size valign colspan align center style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom align right bgcolor cceeff style font family time roman font size valign colspan align center style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom align right valign bottom nbsp valign bottom align right valign bottom nbsp valign bottom align right valign bottom nbsp valign bottom align right valign bottom nbsp valign bottom align right valign bottom nbsp valign bottom align right bgcolor cceeff style font family time roman font size valign colspan align center style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom align right valign bottom nbsp valign bottom align right valign bottom nbsp valign bottom align right valign bottom nbsp valign bottom align right valign bottom nbsp valign bottom align right valign bottom nbsp valign bottom align right bgcolor cceeff style font family time roman font size valign colspan align center style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom align right valign bottom nbsp valign bottom align right valign bottom nbsp valign bottom align right valign bottom nbsp valign bottom align right valign bottom nbsp valign bottom align right valign bottom nbsp valign bottom align right bgcolor cceeff style font family time roman font size valign colspan align center style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom align right valign bottom nbsp valign bottom align right valign bottom nbsp valign bottom align right valign bottom nbsp valign bottom align right valign bottom nbsp valign bottom align right valign bottom nbsp valign bottom align right bgcolor cceeff style font family time roman font size valign colspan align center style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom align right valign bottom nbsp valign bottom align right valign bottom nbsp valign bottom align right valign bottom nbsp valign bottom align right valign bottom nbsp valign bottom align right valign bottom nbsp valign bottom align right bgcolor cceeff style font family time roman font size valign colspan align center style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom align right valign bottom nbsp valign bottom align right valign bottom nbsp valign bottom align right valign bottom nbsp valign bottom align right valign bottom nbsp valign bottom align right valign bottom nbsp valign bottom align right bgcolor cceeff style font family time roman font size valign colspan align center style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom align right valign bottom nbsp valign bottom align right valign bottom nbsp valign bottom align right valign bottom nbsp valign bottom align right valign bottom nbsp valign bottom align right valign bottom nbsp valign bottom align right table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width valign bottom width width valign bottom width width valign bottom width width valign bottom width width valign bottom width width style font family time roman font size valign bottom nowrap style margin margin bottom border bottom solid width font size font family time roman priority valign bottom nbsp valign bottom align center style border bottom solid style margin margin bottom font size font family time roman align center valign bottom nbsp valign bottom align center style border bottom solid style margin margin bottom font size font family time roman align center europe valign bottom nbsp valign bottom align center style border bottom solid style margin margin bottom font size font family time roman align center canada valign bottom nbsp valign bottom align center style border bottom solid style margin margin bottom font size font family time roman align center japan valign bottom nbsp valign bottom align center style border bottom solid style margin margin bottom font size font family time roman align center australia valign bottom nbsp valign bottom align center style border bottom solid style margin margin bottom font size font family time roman align center rest world bgcolor cceeff style font family time roman font size valign colspan align center style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom align right valign bottom nbsp valign bottom align right valign bottom nbsp valign bottom align right valign bottom nbsp valign bottom align right valign bottom nbsp valign bottom align right valign bottom nbsp valign bottom align right bgcolor cceeff style font family time roman font size valign colspan align center style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom align right valign bottom nbsp valign bottom align right valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom bgcolor cceeff style font family time roman font size valign colspan align center style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center schedule style margin margin bottom font size font family time roman align center patent style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width valign bottom width width valign bottom width width valign bottom width width valign bottom width width valign bottom width width style font family time roman font size valign bottom colspan nowrap align center bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom align right valign bottom nbsp valign bottom align right valign bottom nbsp valign bottom align right valign bottom nbsp valign bottom align right valign bottom nbsp valign bottom align right valign bottom nbsp valign bottom align right table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center schedule style margin margin bottom font size font family time roman align center specification style margin margin bottom font size font family time roman specification attached hereto incorporated herein reference style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center schedule style margin margin bottom font size font family time roman align center existing target style margin margin bottom font size font family time roman each target shall comprised certain sequence each identified name accession number provided described below each such sequence shall deemed miragen target style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width valign bottom width style font family time roman font size valign bottom rowspan nowrap style margin margin bottom border bottom solid width font size font family time roman target valign bottom nbsp nbsp valign bottom colspan align center style border bottom solid miragen target valign bottom nbsp style font family time roman font size valign bottom nbsp nbsp valign bottom colspan align center style border bottom solid nbsp name valign bottom nbsp valign bottom nbsp valign bottom colspan align center style border bottom solid nbsp accession nbsp number valign bottom nbsp bgcolor cceeff style font family time roman font size valign rowspan style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp valign bottom nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp bgcolor cceeff style font family time roman font size valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp valign bottom nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp bgcolor cceeff style font family time roman font size valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp valign bottom nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp bgcolor cceeff style font family time roman font size valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp valign bottom nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp bgcolor cceeff style font family time roman font size valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp valign bottom nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp style font family time roman font size valign rowspan style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp valign bottom nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp style font family time roman font size valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp valign bottom nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp style font family time roman font size valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp valign bottom nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp valign bottom nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center schedule style margin margin bottom font size font family time roman align center effect termination target terminated miragen will replaced miragen terminated santaris miragen material breach insolvency style margin margin bottom font size font family time roman style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign miragen give notice termination more miragen target target pursuant section table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign miragen replaces more miragen target target pursuant section nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign santaris terminates more miragen target target pursuant section table style margin margin bottom font size font family time roman each such miragen target target terminated replaced described nbsp nbsp above terminated miragen target then each case upon effective date such termination style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center body html text document